February 23, 2018 | Joanne Morrison

An Expanding Population of Older Americans Makes Vaccination a Top Public Health Issue, UMSOM’s Wilbur Chen, MD, MS, Cautions
Today at a briefing on Capitol Hill, Wilbur Chen, MD, MS, Associate Professor of Medicine at the University of Maryland School of Medicine, warned that the U.S. population of adults 65 and older is expected to rise significantly over the next few decades, making vaccinations against diseases like influenza, pneumonia and shingles for this population very critical.
Citing U.S. government estimates, he said that by 2030, 71 million people in the U.S. will be 65 and older and that number will expand to 90 million by 2050. “As we age, the immune system ages,” Dr. Chen said during a briefing hosted by the Alliance for Health Policy on “Healthy Aging and Immunizations.”
Dr. Chen --Chief of the Adult Clinical Studies section at UMSOM’s Center for Vaccine Development (CVD) and Director of the University of Maryland Travel Medicine Practice-- noted that there are a several vaccines designed for the aging population for diseases such as influenza, pneumococcus, shingles and tetanus.
Older Americans, he said, accounted for roughly 90% of deaths from influenza each year. Dr. Chen also mentioned that vaccination rates for influenza, pneumococcus, and shingles remains low and are an area of needed improvement.
Contact
Office of Public Affairs
655 West Baltimore Street
Bressler Research Building 14-002
Baltimore, Maryland 21201-1559
Contact Media Relations
(410) 706-5260
Related stories

Tuesday, May 01, 2018
UMSOM's Dr. Robert Ferguson Receives Prestigious Dema C. Daley Founders Award for Academic Leadership in Internal Medicine
Robert Ferguson, MD, MACP, Clinical Professor in the Department of Medicine at the University of Maryland School of Medicine (UMSOM), and Director of the UMSOM Professionalism Enhancement Initiative, has been awarded the 2018 Dema C. Daley Founders Award by the Alliance for Academic Internal Medicine (AAIM).

Tuesday, March 20, 2018
UMSOM Vaccine Experts Lead Trial on Avian Flu Vaccine
Vaccine experts at the University of Maryland School of Medicine (UMSOM) have begun multiple clinical trials of vaccines designed to protect against H7N9, an avian influenza virus that was first reported in humans in 2013 in China.

Friday, June 10, 2016
FDA Approves Vaccine for Cholera Invented and Developed at University of Maryland School of Medicine
In a milestone that was years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine’s Center for Vaccine Development, was approved today by the U.S. Food and Drug Administration (FDA).